Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Xiao, Fangsen
3M-RGD, NCT06068179: Graves' Disease Remission Study: MycoMeth Combo	Recruiting	2/3	205	RoW	Mycophenolate Mofetil, Oral, 250 Mg, methimazole, oral, 10mg	The First Affiliated Hospital of Xiamen University	Graves' Disease	10/25	10/26